Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/21/2007WO2007144370A1 New chemical compounds
12/21/2007WO2007144362A1 A suspension comprising benzimidazole carbamate and a polysorbate
12/21/2007WO2007144345A2 Cholecystokinin-1 (cck1) receptor antagonists in the treatment of gastrointestinal and related disorders
12/21/2007WO2007144327A2 Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
12/21/2007WO2007144323A2 Solid forms containing meloxicam with improved taste and process for their preparation
12/21/2007WO2007144315A1 Use of 1,7-dimethylxanthine for the manufacture of a non-anxiogenic psychoanaleptic drug for the treatment of a neuropsychiatric disorder
12/21/2007WO2007144218A1 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma
12/21/2007WO2007144204A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007WO2007144203A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/21/2007WO2007144202A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007WO2007144196A2 Peptide compounds for treating refractory status epilepticus
12/21/2007WO2007144195A2 Pharmaceutical composition with synergistic anticonvulsant effect
12/21/2007WO2007144152A2 Extended step-down estrogen regimen
12/21/2007WO2007144151A1 Step-down estrogen regimen for women receiving estrogen therapy
12/21/2007WO2007144143A1 Method for preparing polymeric matrices by radiation in the presence of sensitive pharmaceutical compounds
12/21/2007WO2007144129A2 Pyrrolidine derivatives useful against diseases that depends on activity of renin
12/21/2007WO2007144128A1 Pyrrolidine compounds as renin inhibitors
12/21/2007WO2007144127A1 Pyrrole derivatives with crth2 receptor modulator activity
12/21/2007WO2007144097A1 New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
12/21/2007WO2007144085A1 Opioid combination wafer
12/21/2007WO2007144083A2 Ache-nmda combination wafer
12/21/2007WO2007144082A2 Combination antihypertensive wafer
12/21/2007WO2007144080A2 Combination antidepressants wafer
12/21/2007WO2007144048A2 Presentation form for the oral administration of phenothiazine dyes, its production and use
12/21/2007WO2007144006A1 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
12/21/2007WO2007144005A1 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
12/21/2007WO2007143951A1 COMPOUNDS WITH THE ACTIVITY OF PPARγ AGONIST AND APPLICATION THEREOF
12/21/2007WO2007143930A1 Use of 20(s)-protopanoxadiol in manufacture of antidepressants
12/21/2007WO2007143897A1 A compound with special property, compositon comprising the compound and its preparation and uses
12/21/2007WO2007143895A1 Supersaturated solution of gemcitabine hydrochloride and prepraration method thereof
12/21/2007WO2007143880A1 Compounds for preventing and treating bacterial infection and its preparation and use
12/21/2007WO2007143858A1 Dph2 gene deletion mutant and uses thereof
12/21/2007WO2007143847A1 Spirotropane compounds
12/21/2007WO2007143825A1 Indoline amide derivatives as ep4 receptor ligands
12/21/2007WO2007143824A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007WO2007143823A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007WO2007143822A1 Sulfamide and sulfamate derivatives as histone deacetylase inhibitors
12/21/2007WO2007127688A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/21/2007WO2007127297A3 Crystalline forms of a dimethylphenyl compound
12/21/2007WO2007127196A3 DIALKYLPHENYL COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
12/21/2007WO2007127163A3 Cns-tumor treatment method and composition
12/21/2007WO2007126964A3 Kinase inhibitors
12/21/2007WO2007126771A3 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
12/21/2007WO2007126745A3 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/21/2007WO2007125562A3 Method for the preparation and use of an enriched cyanidine-s-o-beta-glucopyranoside extract and derivatives thereof from fruits and vegetables containing said anthocyanin and method for the purification and use of cyanidine-3-o-beta- glucopyranoside and derivatives thereof obtained
12/21/2007WO2007124700A3 Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
12/21/2007WO2007124598A3 Softgel capsules with phytosterols and/or phytostanols and optionlly omega polyunstaurated fatty acids
12/21/2007WO2007124250A3 Methods of treating hot flashes with formulations for transdermal or transmucosal application
12/21/2007WO2007124181A3 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
12/21/2007WO2007123939A3 Novel arylamino n-heteraryls as mek inhibitors
12/21/2007WO2007123793A3 Swellable particles for drug delivery
12/21/2007WO2007122634A3 Pyrimidinediones as tyrosine kinase inhibitors
12/21/2007WO2007121916A3 Use of opioid receptor antagonists
12/21/2007WO2007121883A3 1,4:3,6-dianhydromannitol derivatives and use thereof
12/21/2007WO2007121415A3 Chemical compounds
12/21/2007WO2007120523A3 6-(aminoalkyl)indazoles
12/21/2007WO2007119029A3 Co-crystals of calixarenes and biologically active molecules
12/21/2007WO2007118963A3 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
12/21/2007WO2007118323B1 Isoxazole derivatives as calcium channel blockers
12/21/2007WO2007117286A3 Methods for treating cerebrovascular disease by administering desmethylselegiline
12/21/2007WO2007115282A3 Use of ketogenic compounds for treatment of age-associated memory impairment
12/21/2007WO2007115269A3 Orally bioavailable caffeic acid related anticancer drugs
12/21/2007WO2007115192A3 P2x7 antagonists to treat affective disorders
12/21/2007WO2007115047A3 Inhibition of hiv replication and expression of p24 with eif-5a
12/21/2007WO2007113333A3 Antimicrobial preparations
12/21/2007WO2007113266A3 Novel compounds and methods for their production
12/21/2007WO2007112913A3 Benzimidazole derivatives
12/21/2007WO2007112014A3 New therapeutic combinations for the treatment of depression
12/21/2007WO2007111983A8 New therapeutic combinations for the treatment or prevention of psychotic disorders
12/21/2007WO2007106469A3 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/21/2007WO2007106468A3 Formulations of sitaxsentan sodium
12/21/2007WO2007106236A3 Pyrrolo-pyridine kinase modulators
12/21/2007WO2007106063A3 Methods for increasing blood flow and/or promoting tissue regeneration
12/21/2007WO2007105190A3 Amyloid and amyloid-like structures
12/21/2007WO2007105058A3 Pyrazole compounds
12/21/2007WO2007103111A3 Antiviral drugs for treatment of arenavirus infection
12/21/2007WO2007100920A3 Diagnosis and treatment of prostate cancer
12/21/2007WO2007099509A3 Primary amines as renin inhibitors
12/21/2007WO2007095156A3 Taste masking of aerosolized fluoroquinolones
12/21/2007WO2007095043A3 Pharmaceutical formulations
12/21/2007WO2007092452A3 Formulation and method of use for animal ear treatment and homeopathic animal ear treatment
12/21/2007WO2007089787A3 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients
12/21/2007WO2007086080A3 NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
12/21/2007WO2007085451A3 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti -inflammatory agents
12/21/2007WO2007085020A3 Method of treating atrophic vaginitis
12/21/2007WO2007084622A3 Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof
12/21/2007WO2007082079A3 Piperidine amide derivatives as protein kinase inhibitors
12/21/2007WO2007081975A3 Method of treating multiple sclerosis
12/21/2007WO2007081630A3 Substituted pyrimidinyl kinase inhibitors
12/21/2007WO2007079000A3 Kit comprising an osmotic laxative and a stimulant laxative for prepariing the colon for virtual colonoscopy
12/21/2007WO2007076505A3 Transferrin and transferrin-based compositions for diabetes treatment
12/21/2007WO2007076448A3 Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
12/21/2007WO2007064663A3 Process for the preparation of 1-(aminomethyl)cyclohexaneacetic acid
12/21/2007WO2007064620A3 Compositions comprising a combination of ccr5 and cxcr4 antagonists
12/21/2007WO2007063418A3 Substituted indole compounds having nos inhibitory activity
12/21/2007WO2007062399A3 Oncogenic ras-specific cytotoxic compound and methods of use thereof
12/21/2007WO2007062334A8 New pleuromutilin derivative and its use
12/21/2007WO2007062078A3 Thrombopoietin activity modulating compounds and methods
12/21/2007WO2007061676A3 Spirohydantoin aryl cgrp receptor antagonists
12/21/2007WO2007059359A3 Substituted pyrazalones
1 ... 3450 3451 3452 3453 3454 3455 3456 3457 3458 3459 3460 3461 3462 3463 3464 3465 3466 3467 3468 3469 3470 ... 7860